Physician’s Profile
Profile image of Bo  Shen, MD

Bo Shen, MD

Crohn's Disease
Endoscopic Pouch Procedures
Inflammatory Bowel Disease (IBD)
Interventional Endoscopy
Irritable Bowel Syndrome (IBS)
Pouch Disease
Ulcerative Colitis

Bo Shen, MD, is one of the world’s pre-eminent leaders in interventional inflammatory bowel disease (IBD) due to his specialized expertise in treating a wide range of pouch-related disorders. Dr. Shen is the director of the IBD Center at Columbia. He is also the Vice Chair for Innovation in Medicine and Surgery and a Professor of Medicine (in Surgery).

In addition to pouchitis and pouch diseases, Dr. Shen specializes in IBD, GI endoscopy (including endoscopic pouch procedures), and imaging technology. Dr. Shen is known as a pioneer in interventional treatment for IBD - this includes postponing or eliminating the need for surgery in some cases.

Dr. Shen comes to NewYork-Presbyterian from the Cleveland Clinic, where he served as medical director for the Center of Inflammatory Bowel Diseases, Digestive Disease and Surgery Institute. While there, Dr. Shen established a subspecialty Pouchitis Clinic and Interventional IBD Clinic - the first and largest of its kind in the United States. He also created an IBD Board, modeled after oncology tumor boards, to help manage the most challenging cases with multiple specialists.

A prolific researcher in the field with more than 400 peer-reviewed articles, Dr. Shen is funded by a number of government and philanthropic organizations, including the NIH, American College of Gastroenterology, and the Crohn’s and Colitis Foundation of America.

Watch Video Profile


Founder and Chair, American Society for Gastrointestinal Endoscopy, 2018 Special Interest Group in Interventional Inflammatory Bowel Disease

Founder, Global Interventional Inflammatory Bowel Disease Group, 2018

The State of-the-Art Lectureship “Management algorithm in Crohn’s disease”. Chennai IBD 2017. Chennai, India

The State-of-the-Art Lectureship “Interventional IBD”. The 24th International Meeting: Challenges in Managing Inflammatory Bowel Disease 2017, St Vincent University Hospital, Dublin, Ireland

Helio Gastroenterology 200 - Innovators in Gastroenterology and Hepatology, 2016


Khan F, Gao XH, Hull TL, Shen B. Characterization of risk factors for floppy pouch complex in ulcerative colitis. Int J Colorectal Dis 2019 accepted for publication

Lan N, Stocchi L, Delaney CP, Hull TL, Shen B. Endoscopic stricturotomy vs. ileo- colonic resection in the treatment of ileo-colonic anastomotic strictures in Crohn's disease. Gastrointest Endosc 2019 Jan 30 [Epub ahead of print]

Gao XH, Li JQ, Khan F, Chouhan H, Yu Gu, Remer E, Stocchi L, Hull TL, Shen B. Difference in pouchitis incidence between ulcerative colitis and familial adenomatous polyposis: explanation in peripouch fat? Colorectal Dis 2019 Accepted for publication

Wu XR, Zheng XB, Huang Y, Cao Q, Zhang HJ, Miao YL, Zou KF, Chen M, Zhang FM, Mei Q, Gonzalo D, Allende D, Hu PJ, Shen B, Liu XL, Lan P. Risk factors for colorectal neoplasia in patients with underlying inflammatory bowel disease: a multicenter study. Gastroenterol Rep (Oxf) 2019;7:67-73.

Torabi Sagvand B, Edwards, Shen B. Frequency, risk factors, and outcome of gallbladder polyps in patients with primary sclerosing cholangitis: a case-control study. Hepatology Communication 2018;2:1441-1445.

Faleck DM, Winters A, Chablaney S, Shashi P, Meserve J, Weiss A, Aniwan S, Koliani-Pace JL, Kochhar G, Boland B, Singh S, Hirten R, Shmidt E, Kesar V, Lasch K, Luo M, Bohm M, Varma S, Fischer M, Hudesman D, Chang S, Lukin D, Sultan K, Swaminath A, Gupta N, Siegel CA, Shen B, Sandborn WJ, Kane S, Loftus EV Jr, Sands BE, Colombel JF, Dulai PS, Ungaro R. Shorter disease duration is associated with higher rates of response to vedolizumab in patients with crohn's disease but not ulcerative colitis. Clin Gastroenterol Hepatol 2019 Jan 5. [Epub ahead of print]

Lan N, Hull TL, Shen B. Endoscopic sinusotomy versus redo surgery in the treatment of chronic anastomotic sinus in patients with ulcerative colitis. Gastrointest Endosc 2019;89:144-156.

Cummings D, Cruise M, Lopez R, Roggenbuck D, Jairath V, Wang Y, Shen B, Rieder F. Loss of tolerance to glycoprotein 2 isoforms 1 and 4 is associated with Crohn's disease of the pouch. Aliment Pharmacol Ther 2018 Nov 8 [Epub ahead of print]

Shashi P, Shen B. Characterization of megapouch in patients with restorative proctocolectomy. Surg Endosc 2018 Oct 16 [Epub ahead of print]

Meserve J, Aniwan S, Koliani-Pace JL, Shashi P, Weiss A, Faleck D, Winters A, Chablaney S, Kochhar G, Boland BS, Singh S, Hirten R, Shmidt E, Hartke JG, Chilukuri P, Bohm M, Sagi SV, Fischer M, Lukin D, Hudesman D, Chang S, Gao Y, Sultan K, Swaminath A, Gupta N, Kane S, Loftus EV Jr, Shen B, Sands BE, Colombel JF, Siegel CA, Sandborn WJ, Dulai PS. Retrospective analysis of safety of vedolizumab in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2018 Sep 26 [Epub ahead of print]

Lan N, Shen B, Wang JP. Predication of postoperative outcome of colectomy in ulcerative colitis patients using model of end-stage liver disease score. Int J Colorectal Dis 2018;33:1763-1772.

Kapila N, Flocco G, Shen B, Modaresi Esfeh J. The use of vedolizumab in patients with concomitant cirrhosis and Crohn's disease. Cureus 2018;10:e3080.

Navaneethan U, Zhu X, Dennisdhilak D, Lourdusamy V, Shen B, Kiran R. Colorectal cancer resection rates in patients with inflammatory bowel disease: a population-based study. Gastroenterol Rep (Oxford) 2018;6:263-269.

Singh H, Philpott JD, Khan F, Lopez R, Shen B. Vedolizumab for chronic antibiotic refractory pouchitis. Gastroenterol Rep (Oxford) 2018;6:184-188.

DiCaprio D, Lee-Kong S, Stoffels G, Shen B, Al-Mazrou A, Kiran RP, Korelitz B, Swaminath A. Management of iatrogenic perforation during colonoscopy in ulcerative colitis patients: a survey of gastroenterologists and colorectal surgeons. Int J Colorectal Dis 2018 Jul 5 [Epub ahead of print]